# Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

> **NCT05274477** · NA · TERMINATED · sponsor: **Prof. Dominique de Quervain, MD** · enrollment: 8 (actual)

## Conditions studied

- Working Memory
- Post-covid-19

## Interventions

- **DRUG:** Fampridine SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05274477
- **Lead sponsor:** Prof. Dominique de Quervain, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-28
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274477, "Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05274477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*